Journal
NEUROSCIENCE LETTERS
Volume 298, Issue 3, Pages 191-194Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/S0304-3940(00)01753-5
Keywords
Alzheimer's disease; microarrays; synapsin; clinical dementia
Categories
Funding
- NIA NIH HHS [AG13799, AG14239, AG16743] Funding Source: Medline
Ask authors/readers for more resources
Using a cDNA microarray representing 6794 distinct human genes, we identified candidate genes whose expression is altered in cerebral cortex of cases of early Alzheimer's disease (AD); among these was the synaptic vesicle protein synapsin II, which plays an important role in neurotransmitter release. While other candidate genes are presently under investigation in our lab, in this study we discuss the regulation of synapsin gene expression during the transition from normal cognitive function to early AD. We found a selective decrease in the expression of the synapsin splice variants I-III of the a-type isoform in the entorhinal (EC, BM36) but not visual cortex (VC, BM17) of cases characterized by the earliest clinically detectable stage of AD. In contrast, we found no changes in synapsin splice variant II of the b-type isoform. Alteration of synapsin expression at the earliest clinical stage of AD may suggest novel strategies for improved treatment. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available